AfRIG: Biostatistical Methods in Pharmacoepidemiology (Part 1)
Dr. Eworuke received her pharmacy degree from the University of Benin, Nigeria in 2005 and completed her master’s degree in Pharmacology from the University of Oxford, United Kingdom in 2008. Shortly afterwards, Dr. Eworuke joined the Department of Pharmaceutical Outcomes and Policy, College of Pharmacy at the University of Florida and completed her PhD in pharmacoepidemiology in 2013. The same year, she joined the FDA’s Division of Epidemiology, Office of Surveillance and Epidemiology as an epidemiologist supporting the regulatory divisions that cover cardiovascular, renal, pulmonary and rheumatology products.
Currently, Dr. Eworuke is a Master Reviewer Epidemiologist and team lead. As a Master Reviewer, Dr. Eworuke is considered a leading expert on the advanced theories and practices of pharmacoepidemiology and the application of this science in drug safety and regulatory science-related matters. In the team lead position, she oversees epidemiological reviews of study protocols, observational literature, finalized study reports and provides epidemiological recommendations for regulatory decisions. Dr. Eworuke is heavily involved in the design, execution and interpretation of epidemiological studies conducted under the FDA’s Sentinel System. By collaborating with other epidemiologists, statisticians, medical officers, high quality safety evaluations are conducted under FDA’s Active Risk Identification Analysis Systems to support regulatory decisions.
Outside of the FDA, Dr. Eworuke serves as a clinical affiliate assistant professor for the University of Florida, teaching Data Analysis and Advanced Pharmacoepidemiology courses.